The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> BIOLOGY >> NEWS
July 31 deadline approaching to apply for $500,000 in research grants from GlaxoSmithKline

GlaxoSmithKline (GSK) announced today a final call to submit applications for its Drug Discovery and Development Research Grant Program. Researchers working toward breakthroughs in HIV/AIDS drug therapies have until July 31, 2003, to apply.

GSK will award $500,000 in research grants for innovative HIV/AIDS drug research in recognition of the need to produce new alternatives and hope in the fight against the HIV/AIDS pandemic. The one-time research grants range from $25,000 to $150,000 and are intended to further the development of inventive treatments for HIV/AIDS, including therapies aimed at treating infection, prophylactic vaccines, or microbicides designed to prevent transmission of the virus.

For detailed information about the GSK Drug Discovery and Development Research Grant Program, as well as an application, please call 1-888-527-6935 or visit www.dddresearchgrant.com.

Since the inception of the Drug Discovery and Development Research Grant Program in 2001, GSK has honored nine researchers for their groundbreaking work toward new pharmaceutical strategies to combat the HIV virus.

Research grant recipients will be announced in September 2003 at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago. The grants will be paid Nov. 1, 2003.

GlaxoSmithKline is a pharmaceutical industry leader in HIV research and therapies. The company is engaged in basic research programs designed to investigate new targets to treat HIV. In addition to GlaxoSmithKlines Drug Discovery and Development Research Grant Program, the company also provides grants to community based organizations that provide services to those whose lives are most affected by HIV.


'"/>

Contact: Elaine Salewske
esalewske@pcipr.com
312-558-1770
Public Communications Inc.
2-Jun-2003


Page: 1

Related biology news :

1. February 15, 2001, deadline for science writing award
2. Fellowship application deadline for ALLP
3. Brittlestars use crystal lenses to spot approaching predators unique visual system is the first of its kind to be discovered in animals inhabiting the earth today
4. PDF invites scientists pursuing Parkinsons research to apply for funding
5. Principal investigators invited to apply for AACR Breast Cancer Research program
6. Livermore researchers apply combat simulation technology to homeland security
7. $500,000 gift launches new clinical research effort in peripheral neuropathy
8. Leader in cancer treatment and prevention research honored
9. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
10. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
11. Belgian researchers explore revolutionary approach to angiogenesis

Post Your Comments:
(Date:11/6/2009)...erally live in harmony with their arboreal hosts. ...f space in their trees of choice, the ants can get...h, published in the November issue of the America...bore into live trees, and it reopens a centuries-o...nts. , Ants and certain species of plants and tr...
(Date:11/5/2009)...on of Biology Teachers (NABT) will recognize Leona...at Naugatuck Valley Community College (NVCC) in Wa...ation Award during the NABT annual professional de...9 in Denver, Colorado. , The Evolution Education... Biological Sciences,(AIBS) and Biological Scienc...
(Date:11/4/2009)... scientists are reluctant to officially endorse gr...ntinues to grow about its protective effects, incl...Prevention Research , a journal of the American As... reduction in oral cancer. , Vassiliki Papadimi...artment of Thoracic/Head and Neck Medical Oncology...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2EAP Strengthens Service Offerings Through Deal With Broadspire 52301 1EAP Strengthens Service Offerings Through Deal With Broadspire 52301 2EAP Strengthens Service Offerings Through Deal With Broadspire 52301 3Study aims to induce recovery from ankylosing spondylitis 52298 1Study aims to induce recovery from ankylosing spondylitis 52298 2 242 million grant aids study of lung cancer in people who never smoked 9305 1 242 million grant aids study of lung cancer in people who never smoked 9305 2 242 million grant aids study of lung cancer in people who never smoked 9305 3
(Date:11/6/2009)... Calif., Nov. 6 Calbiotech, Inc. a...siness Innovative Research (SBIR) Phase I contract...mmand. Under terms of the agreement, Calbiotech wi...e diagnosis of Dengue virus. ,, Dengue virus...ajor threat to military forces deployed to tropica...
(Date:11/5/2009)...Md., Nov. 5 GenVec, Inc....sults for the third quarter ended September 30, 20....04 per share) for the three months ended Septembe...($0.08 per share) in the comparable quarter of 200...enVec,s net loss was $14.1 million ($0.15 per shar...
(Date:11/5/2009)...l on Thursday, November 5, 2009 at 4:30 p.m. Easte...RNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... ) today reported unaudited financial results for ...30, 2009 and reviewed the Company,s highlights for...nsolidated results reflect the operations of OncoG...
(Date:11/5/2009)... November 5, 2009 Senomy...ng proprietary taste receptor-based technologies t...beverage, and ingredient supply industries, today ... results for the third quarter ended September 30,...uarter of 2009, compared to $4.0 million for the t...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
Other News:
... -- In a landmark decision, the U.S. Patent and ... patent on beagle dogs following a legal challenge..., the American Anti-Vivisection Society (AAVS) and...er for Technology Assessment (ICTA). In the chall...
Low sperm counts could be associated with genomic imprinting disease and could carry a raised risk of transmitting imprinting defects following assisted reproductive technologies, claim researchers in
Redwood City, Calif. May 20, 2004 Verdia Inc., a wholly owned subsidiary of Maxygen, Inc. (Nasdaq: MAXY), announced today the publication in the journal Science of a study that describes the success
... issue of Science (21 May 2004), a team of U.S. an...t destruction has accelerated significantly in Bra...eover, that Amazonian deforestation will likely co... alters its aggressive plans for highway and infra...
Beagles win first round in fight for reprieve from patenting 2Maxygen subsidiary Verdia announces discovery and improvement of glyphosate tolerance gene 2New highways drive accelerating deforestation in Amazonia 2
...-- July 25, 2006 -- Dr. Russell DeBose-Boyd, assis...stern Medical Center, has been named a Distinguish...geles-based W.M. Keck Foundation.... The award of ...researcher's work on the enzymes that regulate and...
...g-Plough Corporation (NYSE: SGP) today reported th... antibiotic AVELOX (moxifloxacin HCl) was as effec...ombination antibiotic regimen in the treatment of ...ns (cIAI), according to results of a study involvi...
In a fascinating new study from the September/October 2006 issue of Physiological and Biochemical Zoology, Daniel A. Hahn (University of Florida) explores the ability of ants to store excess fat and p
...f the conference ...The aim of the conference is t...ial researchers in this field; ... bring together ...esign, analysis and optimization of metabolic path...ular interest are the development and evaluation o...
UT Southwestern scientist named Keck Foundation Distinguished Young Scholar in Medical Research 2UT Southwestern scientist named Keck Foundation Distinguished Young Scholar in Medical Research 3AVELOX as effective as multi-dose combination therapy for intra-abdominal infections 2AVELOX as effective as multi-dose combination therapy for intra-abdominal infections 3Worker ants store fat to share with colony members during times of need 2